Shanghai Pharmaceuticals: Net profit in the first half of 2025 was 4.459 billion yuan, a year-on-year increase of 51.56%.

Shanghai Pharmaceuticals announced that its operating income in the first half of 2025 was 1415.93 billion yuan, an increase of 1.56% compared to the same period last year. Net profit was 4.59 billion yuan, a year-on-year increase of 51.56%.